Skip to content

LENSAR, Inc. LNSR Additional Paid-In Capital

Additional Paid-In Capital at other companies

Staar Surgical logo
Staar SurgicalSTAA
$507.92M+6.5%
Bausch + Lomb logo
Bausch + LombBLCO
$8.58B+1.6%
Schering-Plough logo
Schering-PloughSGP
$368.66M
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$239.47M+10.3%
IAR
Integra LifeSciencesIART
$1.34B+1.3%
ITG
Integer HoldingsITGR
$755.87M+0.2%

Other financials

Income statement

See full
Revenue$13.4M-5.2%
Gross profit$6.4M-10.4%
Operating income$2.2M+139%
Net income$36.3M+233%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$12.5M-36.1%
Total debt$7.6M+206%
Total equity$10.8M+149%
Total assets$66.2M-9.2%

Cash flow

See full
Operating cash flow-$4.3M+38.4%
CapEx$77.0K-31.9%
Free cash flow-

Valuation

See full
Market cap$70.13M-53.1%
Enterprise value$65.21M-54.9%
P/E2.4×
P/S1.2×-1.3×

Profitability

See full
Gross margin45.7%-2.1pp
Operating margin-28.7%+7.3pp
Net margin50.9%+30.7pp
FCF margin-26.6%

Returns & leverage

See full
Return on equity-164%-235pp
Debt / equity0.7×
Current ratio2.4×+0.6×

Where this comes from

Reported directly by LENSAR, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.

The official record: LENSAR, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about LENSAR, Inc.'s additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LENSAR, Inc.'s additional paid-in capital?
LENSAR, Inc. (LNSR) reported additional paid-in capital of $151.91M in Q1 2026.
How has LENSAR, Inc.'s additional paid-in capital changed year-over-year?
LENSAR, Inc.'s additional paid-in capital increased by 2.4% year-over-year, from $148.38M to $151.91M.
What is the long-term trend for LENSAR, Inc.'s additional paid-in capital?
Over 5 years (2020 to 2025), LENSAR, Inc.'s additional paid-in capital has grown at a 3.9% compound annual growth rate (CAGR), from $125.09M to $151.43M.
What does additional paid-in capital mean?
Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.